PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.20%
Some net income increase while CSIQ is negative at -2235.93%. John Neff would see a short-term edge over the struggling competitor.
9.62%
D&A growth of 9.62% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-421.43%
Negative yoy working capital usage while CSIQ is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
172.40%
Inventory growth of 172.40% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
No Data
No Data available this quarter, please select a different quarter.
-598.83%
Negative yoy usage while CSIQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-65.92%
Both negative yoy, with CSIQ at -515.56%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-740.28%
Both yoy CFO lines are negative, with CSIQ at -556.08%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-39.88%
Negative yoy CapEx while CSIQ is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-336.87%
Negative yoy purchasing while CSIQ stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
283.33%
Liquidation growth of 283.33% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-1901.10%
Both yoy lines negative, with CSIQ at -770.24%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-50.68%
Both yoy lines negative, with CSIQ at -770.24%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
83.65%
Issuance growth of 83.65% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.